Process Validation Lifecycle
Process validation is documented evidence that a manufacturing process, operated within defined parameters, consistently produces product meeting its quality attributes. The modern view — set out in the FDA’s 2011 guidance and EU GMP Annex 15 — is a lifecycle: not a one-time three-batch event, but a continuum from process design through qualification into ongoing verification for the life of the product.
What an explainer is not
A topic explainer is SPEQ’s synthesis of what a practice involves, cited to the standards that govern it. It does not reproduce their text, and it does not determine which of them apply to your product or process.
[ POSITION IN THE FRAMEWORK ]
7 DIMENSIONS · 28 LINKSProcess validation runs the longest arc on the map — design through qualification into continued verification — held by the GMP, quality-system, and engineering disciplines and evidenced in the manufacturing systems below.
06 · QUALITY MATURITY — PROCESS VALIDATION LIFECYCLE, REACTIVE TO ADAPTIVE
Validation is a three-batch event; the process runs on precedent, and failures cannot be explained from design knowledge.
A lifecycle policy and PPQ protocols with predefined criteria exist, but Stage 1 understanding of CQAs and CPPs is thin.
CQA/CPP relationships are documented, PPQ batch numbers are risk-justified, and a CPV programme monitors routine production.
CPV statistics detect drift before it becomes a deviation; signals feed back to refine the control strategy.
The design space and process models drive continuous improvement; validation knowledge compounds across the product lifecycle.
SPEQ’s shared five-stage progression, labelled synthesis — not the FDA QMM rating scale. Where does your organization sit? Score your quality system →
07 · REGULATORY & EVIDENCE
GOVERNING STANDARDS · 5
Derived from the 5 standards SPEQ maps to this subject, across 3 regulatory bodies: FDA, EMA, ICH.
RECORDS & OBJECTIVE EVIDENCE
- PPQ protocols and reports with predefined acceptance criteria
- Stage 1 records linking CQAs to CPPs and the control strategy
- A documented justification for the number of PPQ batches
- CPV trending reports with statistical control assessment
- Facility, utility, and equipment qualification supporting Stage 2
COMMON INSPECTION FINDINGS
- PPQ batch count defended by convention rather than justification
- No continued process verification after qualification
- Commercial distribution from a process with unresolved PPQ deviations
- Significant process changes made without revalidation assessment
- Acceptance criteria set after the qualification data were in hand
Stage 1 — Process Design
Validation begins long before the qualification batches. Stage 1 builds process understanding: identifying the critical quality attributes (CQAs) of the product and the critical process parameters (CPPs) that affect them, and establishing the design space and control strategy. This is where ICH Q8 (Pharmaceutical Development) and Quality by Design do their work — you cannot validate a process you do not understand.
A process designed on empirical "it worked last time" reasoning cannot be defended when a batch fails. A process designed on a documented understanding of what drives each CQA can be — and can be improved with confidence.
Stage 2 — Process Qualification (PPQ)
Stage 2 confirms the process design is reproducible at commercial scale. It has two elements: qualification of the facility, utilities, and equipment (the engineering foundation — see Good Engineering Practice and commissioning & qualification), and the Process Performance Qualification (PPQ) batches themselves, manufactured under the commercial control strategy and evaluated against pre-defined acceptance criteria.
The number of PPQ batches is not fixed at three. The lifecycle approach expects the number to be justified by risk and by the process understanding from Stage 1 — a well-understood, well-controlled process may justify fewer or more batches than the legacy default. EU GMP Annex 15 provides the EU expectations for qualification and validation across this stage.
Stage 3 — Continued Process Verification (CPV)
Validation is never "done". Stage 3 provides ongoing assurance that the process stays in a state of control during routine production, using statistical monitoring of parameters and attributes to detect drift and signal when action is needed. CPV turns process validation from an event into a permanent feedback loop, closely tied to the Pharmaceutical Quality System (ICH Q10).
A strong CPV programme is also a strong quality-economics story: it catches variation before it becomes a deviation, a rejected batch, or a recall — reducing the cost of poor quality while continuously improving the process.
One lifecycle, tied to the quality system
The three stages are not independent projects; they are a single lifecycle held together by the quality system. Knowledge from Stage 1 justifies Stage 2; signals from Stage 3 feed back to refine the design space and control strategy. For APIs, ICH Q7 sets the GMP baseline the whole lifecycle sits on.
WORKED EXAMPLE — SPEQ SYNTHESIS
A hypothetical biologics manufacturer has completed process design for a new drug substance and is planning process performance qualification at commercial scale. The programme team proposes three consecutive batches at routine sampling, on the grounds that three is what the site has always done.
Start from the control strategy, because that is what qualification tests
Process performance qualification confirms the strategy developed in design actually holds at scale. A protocol that does not restate the critical quality attributes, the critical process parameters and the controls linking them has nothing specific to confirm.
Treat the batch count as a conclusion, not a premise
The number of runs follows from process variability, prior knowledge and the risk the product carries. "Three, because we always do three" is the premise this step exists to replace; the justification belongs in the protocol whatever number it produces.
Design enhanced sampling to characterise variability, not merely to release
Routine sampling answers whether a batch conforms. Qualification sampling has to answer whether the process is capable and consistent, which needs more points, more positions and sometimes attributes not measured routinely at all.
Close the qualification prerequisites before executing
Facility, equipment, utilities and analytical methods qualified; personnel trained. A qualification run on an unqualified system produces data nobody can use, and the calendar pressure to start anyway is exactly why this is a stated gate.
Run under genuinely commercial conditions
Routine staff, routine shift patterns, routine materials and routine changeovers. A qualification executed by the development team on hand-selected material qualifies something the commercial process will never reproduce.
Define continued process verification before the protocol closes
What will be monitored, at what frequency, against what limits, and what signal triggers action. Leaving this to be designed after qualification is how stage three becomes a filing cabinet rather than a control.
A protocol with a stated control strategy, a justified run count, sampling designed for characterisation, prerequisites treated as gates, commercial execution conditions, and a continued verification plan defined in advance. Whether the process is validated is established by executing this and evaluating the data against those criteria; the conclusion is the quality unit’s determination, which the protocol enables rather than asserts.
WHAT WOULD CHANGE THIS
- If the process uses a platform the site has extensive prior knowledge of, that knowledge legitimately reduces the qualification burden — but the reduction has to be argued from the data, not assumed from familiarity.
- If a critical attribute has no method capable of measuring it at commercial scale, the answer is method development, and proceeding without it produces qualification data with a hole in the middle.
- A continuous process changes the unit of qualification from the batch to a defined period of operation, and the sampling design above does not transfer.
FREQUENTLY ASKED
What are the three stages of process validation?
Stage 1 Process Design (build process understanding — CQAs, CPPs, control strategy), Stage 2 Process Qualification (confirm reproducibility at commercial scale via facility/equipment qualification and PPQ batches), and Stage 3 Continued Process Verification (ongoing statistical assurance that the process stays in control). This lifecycle model comes from the FDA’s 2011 guidance.
Do you still need three validation batches?
Not necessarily. The lifecycle approach replaced the fixed three-batch rule: the number of PPQ batches should be justified by risk and by the process understanding developed in Stage 1. A well-understood process may justify a different number, defended by data rather than convention.
How does process validation relate to Quality by Design?
Quality by Design (ICH Q8) supplies the process understanding that Stage 1 depends on — CQAs, CPPs, design space, and control strategy. Process validation then confirms and maintains that design across the product lifecycle. QbD makes validation defensible; validation makes QbD real in production.